Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$6.3 - $8.95 $137,711 - $195,638
21,859 New
21,859 $177,000
Q4 2023

Feb 13, 2024

SELL
$4.21 - $6.32 $40,618 - $60,975
-9,648 Reduced 38.05%
15,705 $86,000
Q3 2023

Nov 13, 2023

SELL
$5.14 - $11.28 $192,343 - $422,108
-37,421 Reduced 59.61%
25,353 $132,000
Q2 2023

Aug 14, 2023

BUY
$10.01 - $13.86 $252,392 - $349,466
25,214 Added 67.13%
62,774 $725,000
Q1 2023

May 12, 2023

BUY
$11.88 - $26.0 $317,445 - $694,746
26,721 Added 246.53%
37,560 $468,000
Q4 2022

Feb 14, 2023

BUY
$19.14 - $24.55 $14,144 - $18,142
739 Added 7.32%
10,839 $213,000
Q3 2022

Nov 14, 2022

BUY
$22.74 - $31.8 $229,673 - $321,180
10,100 New
10,100 $245,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $189M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.